These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 10692055)

  • 1. Review article: a therapeutic update on dermatomyositis/polymyositis.
    Ghate J; Katsambas A; Augerinou G; Jorizzo JL
    Int J Dermatol; 2000 Feb; 39(2):81-7. PubMed ID: 10692055
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunopathology and treatment of polymyositis and dermatomyositis].
    Hase A; Arahata K
    Nihon Naika Gakkai Zasshi; 1998 Apr; 87(4):664-9. PubMed ID: 9627475
    [No Abstract]   [Full Text] [Related]  

  • 3. Using multi-omics methods to understand dermatomyositis/polymyositis.
    Gao S; Luo H; Zhang H; Zuo X; Wang L; Zhu H
    Autoimmun Rev; 2017 Oct; 16(10):1044-1048. PubMed ID: 28778709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Idiopathic myositis].
    Burgunder JM
    Ther Umsch; 2003 Jul; 60(7):407-12. PubMed ID: 12956034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Intravenous immunoglobulins in the treatment of polymyositis and dermatomyositis].
    Cherin P
    Ann Med Interne (Paris); 2000 May; 151 Suppl 1():1S48-50. PubMed ID: 10896990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Idiopathic inflammatory myopathies: main clinical and immunological variants, difficulties of differential diagnostics and therapy].
    Antelava OA; Nasonov EL
    Klin Med (Mosk); 2014; 92(3):19-25. PubMed ID: 25269190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 64th ENMC International Workshop: therapeutic approaches to dermatomyositis, polymyositis, and inclusion body myositis29-31 January 1999, Naarden, The Netherlands.
    Müller-Felber W; Pongratz D; Reimers C
    Neuromuscul Disord; 2001 Jan; 11(1):88-92. PubMed ID: 11166170
    [No Abstract]   [Full Text] [Related]  

  • 8. The role of intravenous infusions of gamma globulin in the therapy of polymyositis and dermatomyositis.
    Sussman GL; Pruzanski W
    J Rheumatol; 1994 Jun; 21(6):990-2. PubMed ID: 7932446
    [No Abstract]   [Full Text] [Related]  

  • 9. Plasma exchange in polymyositis and dermatomyositis: a multicenter study of 57 cases.
    Cherin P; Auperin I; Bussel A; Pourrat J; Herson S
    Clin Exp Rheumatol; 1995; 13(2):270-1. PubMed ID: 7656479
    [No Abstract]   [Full Text] [Related]  

  • 10. [Plasmapheresis in systemic sclerosis and polymyositis/dermatomyositis].
    Matsuda M
    Nihon Rinsho; 2004 May; 62 Suppl 5():568-71. PubMed ID: 15197986
    [No Abstract]   [Full Text] [Related]  

  • 11. [Established and new therapeutic approaches in dermatomyositis, polymyositis and overlapping syndromes].
    Göttfried I; Seeber A; Anegg B; Pirkhammer D; Rieger A; Stingl G; Volc-Platzer B
    Wien Klin Wochenschr; 1996 Nov; 108(22):705-16. PubMed ID: 9157716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic options in dermatomyositis/polymyositis.
    Boyd AS; Neldner KH
    Int J Dermatol; 1994 Apr; 33(4):240-50. PubMed ID: 8021077
    [No Abstract]   [Full Text] [Related]  

  • 13. Idiopathic inflammatory myopathies.
    Dimachkie MM; Barohn RJ
    Front Neurol Neurosci; 2009; 26():126-146. PubMed ID: 19349710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment consensus for management of polymyositis and dermatomyositis among rheumatologists, neurologists and dermatologists.
    Kohsaka H; Mimori T; Kanda T; Shimizu J; Sunada Y; Fujimoto M; Kawaguchi Y; Jinnin M; Muro Y; Ishihara S; Tomimitsu H; Ohta A; Sumida T
    J Dermatol; 2019 Jan; 46(1):e1-e18. PubMed ID: 30562845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The evidence for immunotherapy in dermatomyositis and polymyositis: a systematic review.
    Vermaak E; Tansley SL; McHugh NJ
    Clin Rheumatol; 2015 Dec; 34(12):2089-95. PubMed ID: 26299472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment consensus for management of polymyositis and dermatomyositis among rheumatologists, neurologists and dermatologists.
    Kohsaka H; Mimori T; Kanda T; Shimizu J; Sunada Y; Fujimoto M; Kawaguchi Y; Jinnin M; Muro Y; Ishihara S; Tomimitsu H; Ohta A; Sumida T
    Mod Rheumatol; 2019 Jan; 29(1):1-19. PubMed ID: 30565491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymyositis and dermatomyositis associated with malignancy: a 30-year retrospective study.
    Wakata N; Kurihara T; Saito E; Kinoshita M
    Int J Dermatol; 2002 Nov; 41(11):729-34. PubMed ID: 12452993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. WITHDRAWN: Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis.
    Choy EH; Hoogendijk JE; Lecky B; Winer JB; Gordon P
    Cochrane Database Syst Rev; 2009 Oct; (4):CD003643. PubMed ID: 19821312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis.
    Choy EH; Hoogendijk JE; Lecky B; Winer JB
    Cochrane Database Syst Rev; 2005 Jul; (3):CD003643. PubMed ID: 16034905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of steroid-resistant polymyositis and dermatomyositis].
    Mimura T; Kanda H; Kubo K
    Nihon Rinsho; 2001 Oct; 59(10):2062-70. PubMed ID: 11676154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.